Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» JNJ
JNJ
J&J's lung cancer therapy succeeds in head-to-head study with AstraZeneca's drug
Reuters
Thu, 09/28/23 - 12:08 pm
JNJ
non-small cell lung cancer
AstraZeneca
Rybrevant
lazertinib
Tagrisso
Janssen and Atropos partner to expedite clinical development
Clinical Trials Arena
Thu, 09/28/23 - 10:10 am
JNJ
Janssen
Atropos Health
real world data
J&J inks 'first of its kind' pact with Singapore government to boost regional life sciences innovation
Fierce Biotech
Wed, 09/27/23 - 11:47 am
JNJ
Singapore
life sciences
JLabs
J&J, IBM face class-action lawsuit over patient data breach
Fierce Pharma
Tue, 09/26/23 - 11:45 am
JNJ
IBM
patients
data
cybersecurity
J&J shines light on key role in multiple myeloma care team, vowing to raise awareness and offer support
Fierce Pharma
Tue, 09/26/23 - 10:10 am
JNJ
Multiple Myeloma
pharma marketing
After Kenvue spinoff, J&J says it's 'uniting' Janssen and medtech segments under one brand
Fierce Pharma
Thu, 09/14/23 - 11:13 pm
JNJ
Janssen
Medtech
rebranding
Johnson & Johnson is getting rid of its script logo after more than 130 years
Stat
Thu, 09/14/23 - 11:09 pm
JNJ
logos
Alex Gorsky joins Neurotech’s board as lead director
Ophthalmology Times
Thu, 09/14/23 - 10:10 am
Alex Gorsky
neurotech
JNJ
AbbVie’s Skyrizi Outperforms J&J’s Stelara in Late-Stage Crohn’s Disease Trial
BioSpace
Wed, 09/13/23 - 11:36 am
AbbVie
Skyrizi
JNJ
Stelara
Crohn's Disease
clinical trials
Doctor asks court to toss J&J lawsuit against her over cancer research
Reuters
Wed, 09/13/23 - 11:26 am
JNJ
legal
free speech
Sandoz to Commercialize Samsung Bioepis’ Biosimilar to J&J’s Stelara
BioSpace
Tue, 09/12/23 - 10:40 am
Sandoz
Samsung Bioepis
biosimilars
JNJ
Stelara
Patent cliffs, divestitures and maturing biotechs all point to more pharma M&A: analysts
Fierce Pharma
Fri, 09/8/23 - 10:29 am
M&A
patent cliffs
Merck
JNJ
Pfizer
GSK
Novartis
Eli Lilly
Novo Nordisk
J&J's patient assistance program suffers data breach, IBM says
Fierce Pharma
Thu, 09/7/23 - 09:43 am
JNJ
Janssen
IBM
patient assistance programs
cybersecurity
J&J sends blood pressure drug back to Idorsia
BioPharma Dive
Wed, 09/6/23 - 11:54 am
Idorsia
JNJ
aprocitentan
hypertension
Despite price drops, J&J gets little reprieve from TB drug saga
Medical Marketing and Media
Wed, 09/6/23 - 10:12 am
JNJ
tuberculosis
generics
bedaquiline
Medicare Will Soon Negotiate Some Drug Prices. Is This a Threat to Johnson & Johnson's Earnings?
Motley Fool
Thu, 08/31/23 - 11:01 am
Medicare
JNJ
drug pricing
Johnson & Johnson's spinoff of Kenvue provides $13.2B in potential M&A firepower
Fierce Pharma
Wed, 08/30/23 - 11:29 pm
JNJ
M&A
consumer health
Kenvue
Biden administration lists 10 drugs for Medicare price negotiation
Medical Marketing and Media
Tue, 08/29/23 - 11:43 am
Medicare
HHS
Pfizer
Bristol Myers Squibb
Eli Lilly
Boehringer Ingelheim
AstraZeneca
AbbVie
Novo Nordisk
JNJ
drug pricing
5 of the best places to work in pharma, according to employees
Pharma Voice
Tue, 08/29/23 - 11:32 am
Glassdoor
Merck
JNJ
Pfizer
GSK
Sanofi
J&J ends R&D at Janssen's infectious disease and vaccine unit
Fierce Biotech
Wed, 08/23/23 - 05:40 pm
JNJ
infectious disease
vaccines
R&D
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »